Health Care & Life Sciences » Biotechnology | China Regenerative Medicine International Ltd.

China Regenerative Medicine International Ltd. | Ownership

Companies that own China Regenerative Medicine International Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
China Orient Asset Management Co., Ltd. (Invt Mgmt)
384,000,000
2.18%
0
0.51%
01/23/2018
Sheng Yuan Asset Management Ltd.
361,363,897
2.06%
-848,073,026
52.75%
04/12/2017
BlackRock Advisors (UK) Ltd.
27,275,000
0.16%
0
0%
09/05/2018
SSgA Funds Management, Inc.
11,168,056
0.06%
20,000
0%
09/06/2018
BlackRock Fund Advisors
7,665,000
0.04%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
6,650,000
0.04%
0
0%
03/31/2018
Parametric Portfolio Associates LLC
4,165,000
0.02%
0
0%
06/30/2018
State Street Global Advisors Ltd.
620,000
0%
0
0%
09/05/2018
UBS Asset Management (UK) Ltd.
180,000
0%
180,000
0%
12/29/2017
Geode Capital Management LLC
75,000
0%
0
0%
07/31/2018

About China Regenerative Medicine International

View Profile
Address
Rooms 3006-10, 30/F
Hong Kong
Hong Kong
Employees -
Website http://www.crmi.hk
Updated 07/08/2019
China Regenerative Medicine International Ltd. is an investment holding company, which engages in in research and development, production and sales of tissue engineering and regenerative medicine products. It operates through the following business segments: Tissue Engineering, Cell, and Cosmetic and Others, and Medical Equipment. The Tissue Engineering segment produces and sells tissue.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.